1295 SNAPSHOT OF TRANSURETHRAL RESECTION OF NEW BLADDER TUMOURS IN THE UK AUDIT (STUKA)

Abstract

You have accessJournal of UrologyBladder Cancer: Detection & Screening1 Apr 20131295 SNAPSHOT OF TRANSURETHRAL RESECTION OF NEW BLADDER TUMOURS IN THE UK AUDIT (STUKA) Amit Patel, Jim Catto, Derek Rosario, and Tim O'Brien Amit PatelAmit Patel London, United Kingdom More articles by this author , Jim CattoJim Catto Sheffield, United Kingdom More articles by this author , Derek RosarioDerek Rosario Sheffield, United Kingdom More articles by this author , and Tim O'BrienTim O'Brien London, United Kingdom More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.02.2649AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Despite transurethral resection of a bladder tumour (TURBT) being the standard management of bladder cancer (BC) there has been no national audit. A methodology, akin to NCEPOD, i.e. a snapshot, was tested as a means of determining the quality of TURBT across the country METHODS Retrospective review of the first case of newly presenting BC undergoing TURBT after midnight on 31st January 2010 from every urologist (n=798) in BAUS. 192 patients were registered from June-August 2011. RESULTS 149 males, 43 females, median age 73 years (27-94). 81% presented with visible haematuria. Diagnostic and surgical quality: Median time to presentation 11 days. Median time to TURBT 27 days. 6% photodynamic diagnosis (PDD) assisted. 61% received single-shot mitomycin-C. 3% returned to theatre. 16% no muscle in the specimen. 31 patients re-resected; no tumours were upstaged or upgraded. Planned management: Non-muscle invasive BC (NMIBC): low risk (n=62); Intermediate risk (n=39); High risk (n=53). In high risk, initial management 58% BCG; 15% FC at 3 months, 11% cystectomy, 16% other. Muscle invasive BC (MIBC) (n=30): 37% radiotherapy, 33% cystectomy, 30% other. Low, intermediate and high risk NMIBC 3 month recurrence: 16%, 30% and 19% respectively. 12 month mortality MIBC 33%; low/intermediate risk NMIBC 0% and high risk NMIBC 2%. CONCLUSIONS Snapshot methodology is a promising tool for surgical audit. A priority is to identify reasons for non-participation and to increase participation in future audits of this type. The quality of initial TURBT in the UK is high. Of note; Delays to TURBT are considerable; PDD is rarely employed; reducing recurrence rates in intermediate risk disease appears to be a priority. © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 4SApril 2013Page: e529 Peer Review Report Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Amit Patel London, United Kingdom More articles by this author Jim Catto Sheffield, United Kingdom More articles by this author Derek Rosario Sheffield, United Kingdom More articles by this author Tim O'Brien London, United Kingdom More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...